Valuation: Terumo Corporation

Market Cap 3,410B 21.53B 18.68B 17.49B 16B 30.21B 2,051B 30.6B 205B 80.32B 1,025B 80.83B 79.07B P/E 2027 *
20.2x
P/E 2028 * 18x
Enterprise Value 3,471B 21.91B 19.01B 17.8B 16.29B 30.75B 2,087B 31.15B 208B 81.74B 1,043B 82.26B 80.48B EV / Sales 2027 *
2.78x
EV / Sales 2028 * 2.55x
Free-Float
97.07%
Yield 2027 *
1.56%
Yield 2028 * 1.74%
1 day+2.64%
1 week+2.11%
Current month+2.11%
1 month+2.11%
3 months+21.26%
6 months+14.09%
Current year+4.54%
1 week 2,255
Extreme 2255
2,376.5
1 month 2,133
Extreme 2133
2,459
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.64%+2.11%-6.21%+6.72% 21.53B
+2.13%+2.23%-17.54%+0.29% 187B
-0.08%+0.25%-3.85%+2.24% 110B
+2.46%+4.09%+14.53%+75.37% 62.02B
+0.65%+3.91%+37.08%+53.44% 53.79B
+3.76%+7.02%+2.70%-34.61% 48.79B
-5.88%-11.78% - - 30.27B
+0.44%+11.38%+8.66%-31.01% 31.33B
-0.69%+2.65%+46.92%-7.06% 24.53B
-0.40%+0.25%+4.78%+2.55% 22.59B
Average +0.50%+1.75%+9.67%+7.55% 59.16B
Weighted average by Cap. +1.06%+2.30%+1.29%+9.30%

Financials

2027 *2028 *
Net sales 1,249B 7.89B 6.84B 6.41B 5.86B 11.07B 751B 11.21B 74.98B 29.43B 375B 29.61B 28.97B 1,329B 8.39B 7.28B 6.82B 6.24B 11.78B 799B 11.93B 79.78B 31.31B 399B 31.51B 30.82B
Net income 169B 1.07B 928M 869M 795M 1.5B 102B 1.52B 10.16B 3.99B 50.88B 4.01B 3.93B 189B 1.19B 1.04B 971M 888M 1.68B 114B 1.7B 11.36B 4.46B 56.86B 4.49B 4.39B
Net Debt 60.46B 382M 331M 310M 284M 536M 36.35B 543M 3.63B 1.42B 18.16B 1.43B 1.4B -22.97B -145M -126M -118M -108M -204M -13.82B -206M -1.38B -541M -6.9B -545M -533M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
07/08/26 ¥2,373.00 +2.64% 4,340,100
06/08/26 ¥2,312.00 +1.05% 4,737,000
05/08/26 ¥2,288.00 -1.51% 4,036,400
04/08/26 ¥2,323.00 +0.50% 2,875,800
03/08/26 ¥2,311.50 -0.54% 3,619,300
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,312.00JPY
Average target price
3,048.46JPY
Spread / Average Target
+31.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock